Astrazeneca PLC (AZN) Shares Active after Upgrade at Zacks Investment Research

Astrazeneca PLC (NYSE: AZN) shares fell back in value on Tuesday February 14 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile U.S. stocks opened slightly lower on Tuesday. The main three benchmarks retreated after touching the latest in a series of record highs on Monday, with the S&P 500 index SPX, -0.09% down two points, or 0.1%, to 2,326.

The Dow Jones Industrial Average DJIA, -0.02% fell 34 points, or 0.2%, to 20,381. The Nasdaq Composite Index COMP, -0.13% shed eight points, or 0.1%, to 5,756.

Analysts at Zacks Investment Research upgraded shares of Astrazeneca PLC (NYSE: AZN) from Hold to Buy today. With a rating of Buy on the stock, the company has a 52-week high of $35.04. The one-year price target of $33.87 is higher than the opening price of $29.37, causing a fair amount of other analysts to report on the stock in recent days. Typically, after analysts give an upgrade report on a stock, they will later issue recurring updates, often followed by a price target change.

Yesterday Astrazeneca PLC (NYSE: AZN) shares last traded at $29.55, which represents a dip of $0.09 compared to the previous closing price. Opening at $29.37, they fluctuated from $29.35 and $29.58 throughout the day.

Astrazeneca PLC (NYSE: AZN) currently has a market cap of 74.76B.

Astrazeneca PLC (NYSE: AZN) Average Daily Trading Volume

1,097,143 shares crossed the trading desk yesterday, 106 percent lower than normal, out of a total float 2,496,047,000. lower than normal. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Astrazeneca PLC (NYSE: AZN) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.

Trades for Astrazeneca PLC (NYSE: AZN) have ranged from $25.55 – 35.0400, and the stock now has a 50-day MA of $27.95 and 200-day MA of $30.01. Today’s last price is 15.67%% lower than the 52 week high of $35.04.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors seek companies that have been successful at growing their earnings by at least 25% over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *